The current valuation score of CorMedix Inc is 9.24, ranking 36 out of 154 in the Pharmaceuticals industry. Its current P/E ratio is 3.36, which is 1769.55% below the recent high of 62.87 and 1348.88% above the recent low of -41.99.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.